All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-30174310

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	30174310	67delD	RT	gag-pol	HIV Infections	D G R	View
2	30174310	A114V	RT	gag-pol	HIV Infections	G R	View
3	30174310	D185A	RT	gag-pol	HIV Infections	G R	View
4	30174310	E138K	RT	gag-pol	HIV Infections	D G R	View
5	30174310	F160A	RT	gag-pol	HIV Infections	G R	View
6	30174310	I142V	RT	gag-pol	HIV Infections	D G R	View
7	30174310	K219Q	RT	gag-pol	HIV Infections	D G R	View
8	30174310	K65R	RT	gag-pol	HIV Infections	D G R	View
9	30174310	K70R	RT	gag-pol	HIV Infections	D G R	View
10	30174310	L74I	RT	gag-pol	HIV Infections	D G R	View
11	30174310	M184V	RT	gag-pol	HIV Infections	D G R	View
12	30174310	M41L	RT	gag-pol	HIV Infections	D G R	View
13	30174310	T165R	RT	gag-pol	HIV Infections	D G R	View
14	30174310	T215F	RT	gag-pol	HIV Infections	D G R	View
15	30174310	T69G	RT	gag-pol	HIV Infections	D G R	View
16	30174310	V75T	RT	gag-pol	HIV Infections	D G R	View
17	30174310	Y115A	RT	gag-pol	HIV Infections	G R	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.